Back
Peyto Exploration & Development Corp. 10K Form
Buy
73
PEYUF
Peyto Exploration & Development Corp.
Last Price:
$16.71
Seasonality Move:
0.91%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PEYUF News And Ratings
See the #1 stock for the next 7 days that we like better than PEYUF
PEYUF Financial Statistics
Sales & Book Value
| Annual Sales: | $618M |
|---|---|
| Cash Flow: | $75.7M |
| Price / Cash Flow: | 13.32 |
| Annual Sales: | $9.85 |
| Price / Book: | 1.72 |
Profitability
| EPS (TTM): | 1.31620 |
|---|---|
| Net Income (TTM): | $264.8M |
| Gross Margin: | $135.2M |
| Return on Equity: | 13.66% |
| Return on Assets: | 6.77% |
Peyto Exploration & Development Corp. Earnings Forecast
Key Peyto Exploration & Development Corp. Financial Ratios
-
The Gross Profit Margin over the past 27 years for PEYUF is 21.87%.
-
The Selling, General & Administrative Expenses for PEYUF have been equal to 1.67% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 34.81% of Operating Income.
-
The Net Earning history of PEYUF is 33.14% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 15 years.
Peyto Exploration & Development Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Oil, Gas & Consumable Fuels |
| Sector: | Energy |
| Current Symbol: | PEYUF |
| Website: | peyto.com |
Debt
| Debt-to-Equity Ratio: | 0.45 |
|---|---|
| Current Ratio: | 0.91 |
| Quick Ratio: | 0.36 |
Price-to-Earnings
| Trailing P/E Ratio: | 16.27 |
|---|---|
| Forward P/E Ratio: | 10.41 |
PEYUF Technical Analysis vs Fundamental Analysis
Buy
73
Peyto Exploration & Development Corp. (PEYUF)
is a Buy
Is Peyto Exploration & Development Corp. a Buy or a Sell?
-
Peyto Exploration & Development Corp. stock is rated a BuyThe current Peyto Exploration & Development Corp. [PEYUF] share price is $16.90. The Score for PEYUF is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.